1. Home
  2. LPL vs PBLS Comparison

LPL vs PBLS Comparison

Compare LPL & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LPL

LG Display Co Ltd AMERICAN DEPOSITORY SHARES

HOLD

Current Price

$3.48

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$37.76

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LPL
PBLS
Founded
1985
N/A
Country
South Korea
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.6B
IPO Year
2004
2026

Fundamental Metrics

Financial Performance
Metric
LPL
PBLS
Price
$3.48
$37.76
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.0M
363.6K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.35
N/A
Revenue Next Year
$2.94
N/A
P/E Ratio
$25.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$25.56
52 Week High
$5.83
$37.83

Technical Indicators

Market Signals
Indicator
LPL
PBLS
Relative Strength Index (RSI) 53.04 65.69
Support Level $2.76 $26.42
Resistance Level $4.37 N/A
Average True Range (ATR) 0.12 2.40
MACD 0.08 0.22
Stochastic Oscillator 85.88 93.64

Price Performance

Historical Comparison
LPL
PBLS

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd manufacture TFT-LCD and OLED technology-based display panels in a broad range of sizes and specifications mainly for use in IT products (comprising notebook computers, desktop monitors and tablet computers), televisions, mobile devices, including smartphones, as well as auto products, and it are one of the world's suppliers of large-sized OLED television panels. It also manufacture display panels for industrial and other applications, including entertainment systems and medical diagnostic equipment.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: